Effects and tolerability of betahistine in patients with vestibular vertigo: results from the Romanian contingent of the OSVaLD study

Abstract

Background and methodsAn efficacy population of 245 patients with vertigo of peripheral vestibular origin was recruited in Romania as part of a 3-month multinational, post-marketing surveillance study of open-label betahistine 48 mg/day (OSVaLD). Endpoints were changes in the Dizziness Handicap Index (primary endpoint), Medical Outcome Study Short-Form 36 (SF-36v2®), and the Hospital Anxiety and Depression Scale.ResultsDuring treatment, the total Dizziness Handicap Index score improved by 41 points (on a 100-point scale). Statistically significant improvements of 12–14 points were recorded in all three domains of the Dizziness Handicap Index scale (P<0.0001). Betahistine therapy was also accompanied by progressive improvements in mean Hospital Anxiety and Depression anxiety and depression scores (P<0.0001) and significant improvements in both the physical and mental component summary of the SF-36v2 (P<0.0001). Betahistine was well tolerated, with only one suspected adverse drug reaction recorded in the Romanian safety population (n=259).ConclusionBetahistine 48 mg/day was associated with improvements in multiple measures of health-related quality of life and had a good tolerability profile in these Romanian patients with recurrent peripheral vestibular vertigo.

Penatalaksanaan Holistik Pasien Vertigo dan Dispepsia Fungsional Pada Ny. M Usia 37 Tahun di Puskesmas Rawat Inap Gedong Air Melalui Pendekatan Kedokteran Keluarga

“…Penggunaan dosis harian 32 sampai 36mg paling efektif dalam pengobatan vertigo. 29 Pasien diberikan Omeprazole 20 mg dua kali sehari yang merupakan golongan proton pump inhibitor (PPI) dapat menghentikan pompa asam ke dalam lambung yang distimulasi oleh sekresi histamin, gastrin dan asetilkolin. 30 Mekanisme dengan menghambat aktivasi adenilil siklase sehingga tidak terjadi peningkatan adenosin monofosfat siklase (cAMP) dan sekresi asam pada lambung berkurang.…”

Acupuncture Points Stimulation for Meniere’s Disease/Syndrome: A Promising Therapeutic Approach

“…All available therapies, indeed, helped substantial patients. However, not all the sufferers were sensitive to the medications which might produce tolerance or side-effects after a long-term intake [ 21 ] or eligible to the surgery. Therefore, complementary and alternative therapy noticed by growing otolaryngology patients [ 22 ] might be a good choice for some people.…”